Advanced

Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia

Ljung, R. LU ; Petrini, P.; Lindgren, A. K. LU and Berntorp, E. LU (1992) In Acta Paediatrica, International Journal of Paediatrics 81(11). p.918-920
Abstract

Twelve children with a severe form of haemophilia A received a totally implantable venous access system (Port-A-Cath) to facilitate regular prophylactic treatment with factor VIII. The indication for implantation was difficulty in obtaining regular access to a peripheral vein. Postoperative bleeding around the portal site occurred in two of 12 cases. After a median duration of follow-up of 26 months (range 5-79 months), one of the systems had needed replacement due to bleeding, septicaemia or thrombosis. One child, with an inhibitor against factor VIII, had an infection at the portal site and this system was removed. None of the other children had any serious side effects. Nine of the 12 children's parents learned how to use the... (More)

Twelve children with a severe form of haemophilia A received a totally implantable venous access system (Port-A-Cath) to facilitate regular prophylactic treatment with factor VIII. The indication for implantation was difficulty in obtaining regular access to a peripheral vein. Postoperative bleeding around the portal site occurred in two of 12 cases. After a median duration of follow-up of 26 months (range 5-79 months), one of the systems had needed replacement due to bleeding, septicaemia or thrombosis. One child, with an inhibitor against factor VIII, had an infection at the portal site and this system was removed. None of the other children had any serious side effects. Nine of the 12 children's parents learned how to use the Port-A-Cath system, thus enabling optimal prophylactic home treatment with factor VIII to be begun early in life.

(Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Central venous catheter, Factor IX, Factor VIII, Haemophilia
in
Acta Paediatrica, International Journal of Paediatrics
volume
81
issue
11
pages
3 pages
publisher
Taylor & Francis
external identifiers
  • Scopus:0026464998
ISSN
0803-5253
DOI
10.1111/j.1651-2227.1992.tb12135.x
language
English
LU publication?
yes
id
ad54dbbc-46f7-4049-947d-2e4edcb2b4e8
date added to LUP
2016-11-08 16:28:01
date last changed
2016-11-25 14:06:36
@misc{ad54dbbc-46f7-4049-947d-2e4edcb2b4e8,
  abstract     = {<p>Twelve children with a severe form of haemophilia A received a totally implantable venous access system (Port-A-Cath) to facilitate regular prophylactic treatment with factor VIII. The indication for implantation was difficulty in obtaining regular access to a peripheral vein. Postoperative bleeding around the portal site occurred in two of 12 cases. After a median duration of follow-up of 26 months (range 5-79 months), one of the systems had needed replacement due to bleeding, septicaemia or thrombosis. One child, with an inhibitor against factor VIII, had an infection at the portal site and this system was removed. None of the other children had any serious side effects. Nine of the 12 children's parents learned how to use the Port-A-Cath system, thus enabling optimal prophylactic home treatment with factor VIII to be begun early in life.</p>},
  author       = {Ljung, R. and Petrini, P. and Lindgren, A. K. and Berntorp, E.},
  issn         = {0803-5253},
  keyword      = {Central venous catheter,Factor IX,Factor VIII,Haemophilia},
  language     = {eng},
  number       = {11},
  pages        = {918--920},
  publisher    = {ARRAY(0xd65b200)},
  series       = {Acta Paediatrica, International Journal of Paediatrics},
  title        = {Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia},
  url          = {http://dx.doi.org/10.1111/j.1651-2227.1992.tb12135.x},
  volume       = {81},
  year         = {1992},
}